Christine Bolen
Pediatric Hematology-Oncology · Charlotte, NCNPI 1750439345
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Bayer at 59.3% of the total. Reporting peaked in 2023 at $9,723 and has fallen 94.6% since, to $524 in 2025.
Across 56 payments — averaging $295.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$10K
- Pierre Fabre Pharmaceuticals, Inc.$4K
- Sanofi$574
- Rigel Pharmaceuticals, Inc.$352
- Novo Nordisk$346
- Amgen$223
- plus $1K from 16 others
Across 61 payments — averaging $10,551 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$574K
- AbbVie$64K
- Daiichi Sankyo Inc.$6K
What the payments were for
- Consulting fees$7,40645%
- Speaking & faculty fees$6604%
- Travel & lodging$5,16331%
- Food & beverage$3,16319%
- Education$1481%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 8 | $9,804 |
| Pierre Fabre Pharmaceuticals, Inc. | 8 | $3,794 |
| Sanofi | 6 | $574 |
| Rigel Pharmaceuticals, Inc. | 4 | $352 |
| Novo Nordisk | 3 | $346 |
| Amgen | 2 | $223 |
| Chiesi USA, Inc. | 3 | $209 |
| Genentech USA, Inc. | 2 | $204 |
| Sobi, Inc | 3 | $200 |
| Agios Pharmaceuticals, Inc. | 2 | $148 |
| Incyte Corporation | 1 | $125 |
| Shire North American Group Inc | 1 | $120 |
| Pharming Healthcare, Inc. | 1 | $120 |
| Merck | 1 | $99 |
| Pfizer | 4 | $49 |
| Adaptive Biotechnologies Corporation | 1 | $41 |
| Kedrion Biopharma, Inc. | 1 | $30 |
| Springworks Therapeutics, Inc. | 1 | $22 |
| RARE Disease Therapeutics, Inc. | 1 | $21 |
| Genentech, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Vertex | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,540 in reported general payments places this provider in the 70th percentile of 57 pediatric hematology-oncology providers in North Carolina.
See all pediatric hematology-oncology providers in North Carolina →
Other pediatric hematology-oncology in Charlotte
- Javier OesterheldCharlotte$140K
- Paulette BryantCharlotte$126K
- Philip RoehrsCharlotte$45K
- Joel KaplanCharlotte$44K
- Michael KentCharlotte$17K
- Brendan KleiboerCharlotte$16K
- Ashley HinsonCharlotte$8K
- Andrew GilmanCharlotte$4K
- Peter AndersonCharlotte$3K
- Joanne McManamanCharlotte$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.